Skip to main content

LMR Partners LLP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1578621 LONDON, X0

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,908,683
+$13,798,196 QoQ
Shares Held
22,306
+15498.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#248
of 1,297 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$24,318,060
PutShares
39,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,480,644 across 75 Biotechnology names. REGN ranks #3 (7.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
22,306 $13,908,683

All Filings in REGN

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,908,683 22,306
2026-06-30 $24,318,060 39,000
2026-03-31 $30,132,960 39,000
2026-03-31 $110,487 143
2025-12-31 $90,308 117
2025-12-31 $3,859,350 5,000
2025-09-30 $8,756,792 15,574
2025-09-30 $2,811,350 5,000
2025-06-30 $4,987,500 9,500
2025-06-30 $22,913,100 43,644
2025-06-30 $51,345,000 97,800
2024-09-30 $240,733 229
2024-03-31 $189,610 197
2024-03-31 $5,004,948 5,200
2024-03-31 $1,154,988 1,200
2023-12-31 $4,567,108 5,200
2023-12-31 $148,431 169
2023-12-31 $1,053,948 1,200
2023-09-30 $408,188 496
2023-09-30 $987,552 1,200
2023-09-30 $4,279,392 5,200
2023-06-30 $584,173 813
2023-06-30 $5,101,634 7,100
2022-12-31 $7,046,071 9,766
2022-06-30 $1,520,977 2,573
2022-03-31 $322,670 462
2021-09-30 $1,595,859 2,637
2021-06-30 $491,515 880
2020-12-31 $785,053 1,625
2020-06-30 $10,774,177 17,276
2020-03-31 $740,735 1,517